Two strategic biopharmaceutical collaborations were announced, each merging one company’s innovative biologic technology with a second company that can drive potential therapeutics over the finish line to commercialization.
A federal judge on March 21 said Apple Inc. must face a Silicon Valley company’s claims it illegally monopolized the U.S. market for heart rate monitoring apps for the Apple Watch.
Alnylam is suing both Moderna and Pfizer over what it claims are patent infringements related to the Cambridge, Massachusetts-based company’s biodegradable cationic lipids that it says have been foundational to the success of the mRNA-based COVID-19 vaccines developed by the two companies.
As the health industry rapidly shifts to more patient-centric approaches to care and clinical research, technology is just as quickly becoming the cornerstone to effectively engage clinical study participants. Electronic clinical outcome assessments (eCOAs) are essential to ensuring that each clinical trial is optimized for the patient’s experience by being faster, more on-demand, and more customizable. Kris Gustafson – Vice President and Global Head IQVIA eCOA, IQVIA – discusses three key reasons to implement an eCOA strategy for clinical trials.
Greater Than One President Matthew Howes forecasts five healthcare marketing trends for 2022.
Remember back in March and April and May of 2020, when people prefaced their plans for the future with, “When we get back to normal”? We never did, and we never will. The COVID experience has forever changed how all of us view the world, how we interact with each other … and, of course, how we interact with healthcare brands and what we expect from them. In seeking out insights from pharma’s wise heads for Med Ad News’ annual Agenda report, we tried to maneuver around COVID at least a little, to see what else was going on in the industry. But the plain fact is that we couldn’t, not really.
Medable Inc., the leading software provider for patient-centered clinical trials, launched the Medable Partner Network – uniting a diverse ecosystem of technology, service, data, site, and direct-to-patient partners that work together to accelerate deployment of decentralized clinical trials.
With the increased number of channels available to reach healthcare professionals alongside dramatically fewer in-person opportunities due to institutional restrictions, pharma marketers are facing more challenges than ever before to break through the noise. The traditional sales pitches and mass emails are a thing of the past with the growing need to create a personalized digital strategy to reach healthcare providers.
Amid the turmoil of the recurring waves of the pandemic, pharma marketers are shifting their focus to new and innovative solutions to engage healthcare professionals (HCPs), which has led to acceleration of programmatic messaging technologies in the sector.
After Moderna roared through 2021 on the strength of the company’s COVID-19 vaccine, the mRNA giant forged a partnership with Carisma Therapeutics to develop and commercialize in vivo engineered chimeric antigen receptor monocyte (CAR-M) therapeutics for different forms of cancer.